A study revealed that high expression of p53R2 was significantly correlated with a better survival of patients with late-stage colorectal cancer [14], another literature demonstrated that high expression of p53R2 is associated with tumor progression in patients with esophageal squamous cell carcinoma [15]. Here, RRM2B is linked to esophageal squamous cell carcinoma.